Intriguingly, Ccr2 and Ccl2, two proteins that are preferentially expressed in tumor cells and are critical for cancer cell proliferation (111, 112), were strongly downregulated (Fig. 2B and C), suggesting a potential mechanism through which I-BRD9 inhibits AML but not HEK293T cell growth. The gene discussed is CCL2; the disease is cancer.